Top compounds associated with response to RGMA


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.067 0.02
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.075 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.074 0.02
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.12 0.02
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.082 0.02
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA PI-103 GDSC1000 pan-cancer AAC 0.073 0.02
Download CSV